Yuan‐Cheng Chu
Papers
3
Total Citations
15
H-Index
3
About
Dr. Yuan‐Cheng Chu is a pioneering urologic oncology researcher whose work centers on prostate cancer prognosis, surgical outcomes, and the tumor microenvironment. His most impactful contribution is the development of an artificial intelligence model that interprets postoperative cystography features to predict recovery from postprostatectomy urinary incontinence—a breakthrough that offers clinicians a rapid, non-invasive tool for functional outcome prediction. This study, published in 2023, has already garnered 8 citations, reflecting its immediate relevance. Dr. Chu also identified key clinical predictors of biochemical failure in patients with positive surgical margins after robotic-assisted radical prostatectomy, providing critical guidance for postoperative surveillance. In a novel 2024 study, he demonstrated that periprostatic adipose tissue may paradoxically inhibit tumor progression by secreting apoptotic factors, suggesting a natural immune-mediated barrier during early-stage prostate cancer. This work challenges conventional assumptions about obesity and cancer risk. With a research portfolio that bridges artificial intelligence, surgical oncology, and tumor biology, Dr. Chu is shaping next-generation strategies for prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3